Piperazines
US7294626B2 · kind B2 · utility
14Cited by
2References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 18, 2006 |
| Grant date | Nov 13, 2007 |
| Priority date | — |
| Expiry date | Jan 18, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates, inter alia, to novel piperazines of the following formula:to the use of these compounds in the preparation of pharmaceutical compositions, to pharmaceutical compositions comprising the compounds, and to methods of treatment employing these compounds or compositions. The compounds show a high and selective binding affinity for the histamine H3 receptor, indicating histamine H3 receptor antagonistic, inverse agonistic or agonistic activity. As a result, the compounds are useful for the treatment of diseases or disorders related to the histamine H3 receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.